Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fei-Fei Tang

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2020
Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating FactorFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell TransplantFei-Fei Tang, Yu-Qian Sun, Xiao-Dong Mo, et al.
Pediatric Transplantation|August 3, 2020
The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantationFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2019
Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell TransplantationFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
British Journal of Haematology|December 1, 2025
Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insightsLin-Ya Wang, Hai-Tao Gao, Qiang Fu, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 25, 2017
Risk factors for herpes simplex virus-1/2 viremia and clinical outcomes following unmanipulated haploidentical haematopoietic stem cell transplantationFei-Fei Tang, Xiao-Su Zhao, Lan-Ping Xu, et al.
Zhonghua Nei Ke Za Zhi|February 8, 2014
[The efficacy and safety of modified busulfan/fludarabine conditioning regimen in elderly or drug-intolerable patients with hematologic malignancies]Feng-rong Wang, Xiao-jun Huang, Dai-hong Liu, et al.
British Journal of Haematology|February 3, 2018
N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplantYuan Kong, Yang Song, Fei-Fei Tang, et al.
Cancer Letters|May 22, 2025
N-acetyl-L-cysteine promoted hematopoietic recovery in patients with acute myeloid leukemia after complete remission--A pilot studyLi-Juan Hu, Chen-Yuan Li, Tong Xing, et al.
Bone Marrow Transplantation|July 9, 2021
Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignanciesFei-Fei Tang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 7, 2020
Incidence, Risk Factors, and Outcomes of Chronic Graft-versus-Host Disease in Pediatric Patients with Hematologic Malignancies after T Cell-Replete Myeloablative Haploidentical Hematopoietic Stem Cell Transplantation with Antithymocyte Globulin/Granulocyte Colony-Stimulating FactorFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 21, 2020
Incidence, Risk Factors, and Outcomes of Primary Prolonged Isolated Thrombocytopenia after Haploidentical Hematopoietic Stem Cell TransplantFei-Fei Tang, Yu-Qian Sun, Xiao-Dong Mo, et al.
Pediatric Transplantation|August 3, 2020
The incidence, risk factors, and outcomes of acute graft-vs-host disease in pediatric T-cell-replete haploidentical hematopoietic stem cell transplantationFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 10, 2019
Basiliximab as Treatment for Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Patients after Haploidentical Hematopoietic Stem Cell TransplantationFei-Fei Tang, Yi-Fei Cheng, Lan-Ping Xu, et al.
British Journal of Haematology|December 1, 2025
Decoding the molecular drivers of TP53-mutant acute myeloid leukaemia: Clinical implications and prognostic insightsLin-Ya Wang, Hai-Tao Gao, Qiang Fu, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|August 25, 2017
Risk factors for herpes simplex virus-1/2 viremia and clinical outcomes following unmanipulated haploidentical haematopoietic stem cell transplantationFei-Fei Tang, Xiao-Su Zhao, Lan-Ping Xu, et al.
Zhonghua Nei Ke Za Zhi|February 8, 2014
[The efficacy and safety of modified busulfan/fludarabine conditioning regimen in elderly or drug-intolerable patients with hematologic malignancies]Feng-rong Wang, Xiao-jun Huang, Dai-hong Liu, et al.
British Journal of Haematology|February 3, 2018
N-acetyl-L-cysteine improves mesenchymal stem cell function in prolonged isolated thrombocytopenia post-allotransplantYuan Kong, Yang Song, Fei-Fei Tang, et al.
Cancer Letters|May 22, 2025
N-acetyl-L-cysteine promoted hematopoietic recovery in patients with acute myeloid leukemia after complete remission--A pilot studyLi-Juan Hu, Chen-Yuan Li, Tong Xing, et al.
Bone Marrow Transplantation|July 9, 2021
Comparison of the clinical outcomes between NIMA-mismatched and NIPA-mismatched haploidentical hematopoietic stem cell transplantation for patients with hematological malignanciesFei-Fei Tang, Xiang-Yu Zhao, Ming-Rui Huo, et al.
Pageof 6